The Food and Drug Administration the week of Oct. 23 cleared for marketing the first over-the-counter test to detect fentanyl in urine. The five-minute test provides only preliminary results and includes a pre-addressed mailing box for shipping samples to the manufacturer’s laboratory for confirmation testing using an alternative chemical method. The agency expedited review of the Alltest Fentanyl Urine Test Cassette, clearing it only 16 days after the submission was received.

“Opioid abuse, misuse and addiction is one of the most profound public health crises facing the U.S. today,” said Jeff Shuren, M.D., director of FDA’s Center for Devices and Radiological Health. “…This test is an example of the FDA’s continued commitment to authorize tools that can reduce deaths associated with overdoses.”

Related News Articles

Headline
Released during National Eating Disorder Awareness week, the latest AHA People Matter, Words Matter poster encourages compassionate and caring language when…
Headline
The Substance Abuse and Mental Health Services Administration Feb. 8 issued a final rule implementing Coronavirus Aid, Relief, and Economic Security Act…
Headline
The Substance Abuse and Mental Health Services Administration Jan. 31 updated its Overdose Prevention and Response Toolkit, which includes basic information on…
Headline
The Substance Abuse and Mental Health Services Administration Jan. 31 issued a final rule that updates certain regulations for Opioid Treatment Programs and…
Headline
The House Dec. 12 voted 386-37 to pass AHA-supported legislation (H.R. 4531) that would reauthorize key SUPPORT Act programs for patients with substance use…
Headline
The AHA Dec. 7 sent a letter supporting the Support for Patients and Communities Reauthorization Act (H.R. 4531), bipartisan legislation that would reauthorize…